- Home
- STOK vs LE Comparison
STOK vs LE Comparison
Compare STOK & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- LE
- Stock Information
- Founded
- STOK 2014
- LE 1963
- Country
- STOK United States
- LE United States
- Employees
- STOK N/A
- LE N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- LE Clothing/Shoe/Accessory Stores
- Sector
- STOK Health Care
- LE Consumer Discretionary
- Exchange
- STOK Nasdaq
- LE Nasdaq
- Market Cap
- STOK 379.6M
- LE 323.8M
- IPO Year
- STOK 2019
- LE N/A
- Fundamental
- Price
- STOK $7.69
- LE $9.17
- Analyst Decision
- STOK Strong Buy
- LE Strong Buy
- Analyst Count
- STOK 6
- LE 2
- Target Price
- STOK $26.00
- LE $20.00
- AVG Volume (30 Days)
- STOK 987.9K
- LE 158.5K
- Earning Date
- STOK 05-05-2025
- LE 06-04-2025
- Dividend Yield
- STOK N/A
- LE N/A
- EPS Growth
- STOK N/A
- LE N/A
- EPS
- STOK N/A
- LE 0.20
- Revenue
- STOK $36,555,000.00
- LE $1,362,935,000.00
- Revenue This Year
- STOK $27.80
- LE $4.26
- Revenue Next Year
- STOK $9.53
- LE $2.67
- P/E Ratio
- STOK N/A
- LE $45.92
- Revenue Growth
- STOK 316.34
- LE N/A
- 52 Week Low
- STOK $5.35
- LE $8.15
- 52 Week High
- STOK $17.58
- LE $19.88
- Technical
- Relative Strength Index (RSI)
- STOK 53.59
- LE 41.91
- Support Level
- STOK $7.31
- LE $8.76
- Resistance Level
- STOK $7.99
- LE $9.25
- Average True Range (ATR)
- STOK 0.61
- LE 0.61
- MACD
- STOK 0.23
- LE 0.00
- Stochastic Oscillator
- STOK 88.64
- LE 38.06
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.